COVID-19 IN PREGNANCY AND BREASTFEEDING
Abstract
COVID-19 represents a global crisis, because it is an emerging disease with a rapid increase in cases and deaths since its first identification in Wuhan, China in December 2019. In the midst of this outbreak, attention has been focused on a group vulnerable people, pregnant women. It has been described that the SARS-coV-2 virus has a predilection for the ECA2 receptor present at the placental level, conditioning an intrauterine growth restriction and/or preterm delivery. In addition to the above, concerns have been raised about whether the SARS-CoV-2 virus could be transmitted from the COVID-19 positive mother to the newborn through breast milk. That is why in this work a compilation of results of epidemiological studies on the effects of COVID-19 during pregnancy and breastfeeding was addressed.
Downloads
References
Borges Cavalcante M., Torres de Melo Bezerra Cavalcante C., & Sampaio Braga A. C. COVID-19 Treatment: Drug Safety Prior to Conception and During Pregnancy and Breastfeeding. Geburtshilfe Frauenheilkd, 2021, 81(01): 46-60.
Kotlar Bethany, Emily Gerson, Sophia Petrillo, Ana Langer , & Henning Tiemeier. The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review. Reproductive Health volume, 2021, 18 (10): 1-39.
DeBolt CA., Bianco A, L, Limaye MA, Silverstein J., Penfield CA., Roman AS, . . . Bernstein. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obst Gynecol 2019; XX (xx): xx-xx.
Delahoy MJ. (2020). Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19-COVID-NET, 13 States, March 1–August 22, 2020. Morbidity and Mortality Weekly Report: MMWR, 2020; 69 (38): 1347-1354.
Harshil Bhatt. Should COVID-19 Mother Breastfeed her Newborn Child? A Literature Review on the Safety of Breastfeeding for Pregnant Women with COVID-19. Maternal and Childhood Nutrition, 2021;50-62.
Khalil A., Von Dadelszen P., Draycott T., & Ugwumadu A. Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic. JAMA, 2020, 324 (7): 705-706.
Muralidar S., Ambi SV., Sekaran S, & Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARSCoV-. Biochimie, 2020, 85-100.
Wu C., Yang W., Wu X., Zhang T., Zhao Y., Ren W., & Xia J. Clinical manifestation and laboratory characteristics of SARS-CoV-2 infection in pregnant women. Virologica Sinica, 2020, 35 (16): 305-310.
Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, Meaney-Delman D. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–October 3, 2020. Morbidity and Mortality Weekly Report, 2020, 69 (44); 1641–1647.
